Skip to main content
Pierre-Yves Desprez, Ph.D.

Pierre-Yves Desprez, Ph.D.

Investigator

The Desprez laboratory is focused on helix-loop-helix transcriptional regulators, and their role in controlling normal and cancerous epithelial cell phenotypes. Id proteins—negative regulators of basic helix-loop-helix transcription factors—have been identified as a critical regulator of proliferation and migration/invasion. Dr. Desprez and his colleagues found that Id genes and proteins not only correlate with but also determine the level of aggressiveness of human breast and prostate cancer cells, and that Id-1 regulates multiple tumor-promoting pathways in brain cancer (glioblastoma). In collaboration with CPMC scientist Dr. Sean McAllister, recent investigations by Dr. Desprez have determined that cannabidiol (CBD), a cannabinoid with a low toxicity profile, inhibits human cancer cell proliferation and invasion through differential modulation of specific pathways, and down-regulates Id-1 gene expression. CBD also up-regulates the pro-differentiation factor Id-2 in breast cancer cells.

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?